zolmitriptan has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelman, JU; Lewit, EJ | 1 |
| Diener, HC; Evers, S | 1 |
1 review(s) available for zolmitriptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Comparative aspects of triptans in treating migraine.
Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |
1 trial(s) available for zolmitriptan and Cardiovascular Diseases
| Article | Year |
|---|---|
Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
Topics: Administration, Intranasal; Adult; Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dizziness; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Nausea; Oxazolidinones; Patient Satisfaction; Product Surveillance, Postmarketing; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Tryptamines | 2007 |